Recent research indicates that GLP-1 weight-loss drugs, such as semaglutide, may not only aid in weight management but also extend lifespan in older female mice. The study found that these mice lived approximately 12 percent longer than their untreated counterparts, suggesting p…
As metabolic health gains prominence in wellness discussions, the roles of NAD+ and GLP-1 therapies are increasingly scrutinized. This article clarifies how GLP-1 medications like…
The FDA has approved Eli Lilly's medication Mounjaro for reducing the risk of heart events in individuals with Type 2 diabetes. This approval adds to the drug's existing use for b…
This article examines the potential of GLP-1 receptor agonists, commonly used for type 2 diabetes and obesity, in treating polyendocrine metabolic ovarian syndrome (PMOS). Experts…
The first generic weight loss medication has been launched in South Africa, sparking discussions about its affordability and accessibility. Mia Malan, founder of the Bhekisisa hea…
GLP-1 receptor agonists, initially developed for diabetes treatment, are being studied for their effects on weight loss and metabolic health in older adults. Recent research sugge…
Researchers at UC Berkeley have discovered that the compound TOFA can enhance energy expenditure and reduce body fat without causing muscle loss in mice. This approach contrasts w…
Recent data indicates a potential decline in obesity rates in the United States, marking a significant shift in a longstanding public health issue. This change coincides with the…
As obesity medications evolve, researchers are exploring new hormone combinations to enhance treatment effectiveness and tolerability. Current studies focus on therapies that not…
GLP-1 medications, while effective for weight loss and improving metabolic health, may also lead to emotional flatness in some users, described as the 'meh' effect. This phenomeno…
New research from Yale University has uncovered surprising effects of Ozempic, a GLP-1 medication, on hunger neurons in the brain. Contrary to previous beliefs that these neurons…
Dr. Loren Rourke, a Texas-based breast surgical oncologist, highlights five everyday habits that may help reduce cancer risk and improve health outcomes. While no lifestyle choice…
Beauty industry leaders are ramping up efforts to develop treatments specifically designed for those experiencing facial volume loss, promising to redefine the standards of beauty…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
In a stunning twist of regulatory fate, the FDA has issued new hair-raising guidelines for users of GLP-1 drugs like Ozempic and Mounjaro, warning of a 37-68% increased risk of ha…